Glycogen synthase kinase-3b (GSK-3b/zeste-white-3/shaggy) is a negative regulator of the wnt signaling pathway which plays a central role in the development of invertebrates and vertebrates; loss of function and dominant negative mutations in GSK-3b lead to activation of the wnt pathway in Drosophila and Xenopus. We now provide evidence that lithium activates downstream components of the wnt signaling pathway in vivo, leading to accumulation of b-catenin protein.
INTRODUCTION
. The hypothesis is based on the observation that lithium inhibits inositol monophosphatase (IMPase) in vitro (Berridge et al., 1989;  Hallcher and Lithium perturbs the development of diverse organisms Sherman, 1980) . Inhibition of IMPase is believed to lead to including Xenopus, zebrafish, Dictyostelium, and sea urdepletion of endogenous inositol, preventing the formation chins. In Xenopus embryos, lithium treatment causes an of inositol tris-phosphate (IP 3 ). In support of this hypothesis, expansion of dorsal mesoderm, leading to formation of a coinjection of myo-inositol with lithium prevents the tesecond dorsal axis (Kao et al., 1986) . In Dictyostelium, lithratogenic actions of lithium in Xenopus embryos (Busa and ium alters cell fate determination, blocking spore cell for- Gimlich, 1989) . However, when IMPase is inhibited commation and promoting stalk development (Maeda, 1970) .
pletely in Xenopus embryos using the IMPase inhibitor Treatment of sea urchin animal blastomeres with lithium L690,330 (Atack et al., 1993) , which is 1000 times more causes them to display a morphology resembling that of potent than lithium, the embryos develop normally (Klein isolated vegetal blastomeres (Horstadius, 1973) .
and Melton, 1996) . Thus, inhibition of IMPase is not suffiThe inositol depletion hypothesis is a widely accepted cient for dorsalization of Xenopus embryos. Furthermore, explanation of the developmental effects of lithium, as well mutants in Dictyostelium discoideum lacking phospholias the neuropsychiatric effects of lithium (Berridge et al., pase C (and unable to generate IP3 in response to extracellular signals) also develop normally, indicating that an intracellular rise in IP 3 is not necessary for spore cell develop-indicate that the developmental effects of lithium are medi-
MATERIALS AND METHODS
ated by another target or pathway. Because of the close similarities between lithium treatMaterials. Purified, bacterially expressed GSK-3 was purchased ment and ectopic activation of the wnt signaling pathway from New England Biolabs. b-Catenin protein, plasmid, and antiin Xenopus, we have investigated whether lithium acts on bodies were generous gifts from Ursula Gluck and Barry Gumbiner a component of the wingless/int (wnt) signaling pathway (Memorial Sloan Kettering) . Xenopus GSK-3b plasmids (XG73 and (Klein and Melton, 1996) . The wnt pathway is a highly con-XG114) were kindly provided by David Kimelman (University of Washington). The collagenase promoter (AP-1) -luciferase conserved signaling pathway that regulates cell fate decisions in struct was obtained from Nancy Colburn (NCI; Angel and Karin, vertebrates and invertebrates (reviewed in Perrimon, 1994 Perrimon, , 1991 Dong et al., 1996) . [g-32 P]ATP was from Amersham. Western 1996; Miller and Moon, 1996) . Much of the pathway has analysis was performed using enhanced chemiluminescence (ECL, been determined from detailed genetic analysis in Drosoph-
ila. At present, identified components of this signaling pathOocytes, embryos, and microinjection. Stage 6 Xenopus ooway include wnts (the secreted ligands), frizzled (the wnt cytes were obtained by collagenase treatment of excised ovaries receptor), and the intracellular mediators disheveled, zeste- (Smith et al., 1994) and were microinjected with 10 nl for RNA white 3/shaggy (or GSK-3b), and armadillo (or b-catenin; see and 10 -20 nl for tau protein.
Oocytes were cultured at 18ЊC in above reviews). In 10T1/2 cells, wingless signaling inhibits OR2/ (82.5 mM NaCl, 2.5 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2, GSK-3b enzymatic activity (Cook et al., 1996) , consistent sophila (Peifer et al., 1994; van Leeuwen et al., 1994) as then returned to 0.11 MMR. For DN-GSK-3 RNA and myo-inositol well as Xenopus (Yost et al., 1996) . This is associated with injections, embryos were injected in the subequatorial region of a a translocation of b-catenin to the nucleus in cells re- Yost et al., 1996) . In addition, ectopic expression assess the level of DN-GSK-3 protein translated from the injected of conserved genes, including wnts, disheveled, and b-ca-RNA, and the rest of the embryos were scored at stages 30-35. tenin, leads to second axis formation in Xenopus, similar to GSK-3 assays. In vitro phosphorylation of tau was performed as described previously (Klein and Melton, 1996) , except that the lithium treatment. Our attention was focused on glycogen reactions were incubated at 25ЊC and bacterially expressed tau (50 synthase kinase-3b (zeste-white 3/shaggy) based on the obmg/ml) was used. Samples were taken at 0, 5, 10, 15, 20, 25, and servations that disruption of the Dictyostelium GSK-3b 30 min, adjusted to 11 Laemmli sample buffer, and analyzed by gene (Harwood et al., 1995) is phenocopied by lithium treatpolyacrylamide gel electrophoresis (7.5% SDS gels). After electroment (Maeda, 1970) and that expression of a dominant negaphoresis, gels were either fixed and dried for autoradiography or tive mutant of GSK-3b causes duplication of the dorsal axis transferred to nitrocellulose for Western blotting. To measure in in Xenopus, also similar to lithium treatment (Dominguez vivo phosphorylation of tau by GSK-3b, RNA (10 ng) encoding He et al., 1995; Pierce and Kimelman, 1995) .
Xenopus or Dictyostelium GSK-3b was injected into stage 6 ooTherefore, we have previously proposed that the diverse cytes. After 16 hr (at 18ЊC), 10-20 ng tau protein was injected and developmental effects of lithium are mediated through dioocytes were incubated (23ЊC) for the times indicated in the figures. For lithium treatment, oocytes were transferred to OR2/ conrect inhibition of GSK-3b (Klein and Melton, 1996) . In suptaining 20 mM LiCl for 10 min prior to tau injection and were port of this hypothesis we have shown that lithium, but returned to the OR2//LiCl after injection. For each sample, 10 not other monovalent cations, inhibits purified GSK-3b in oocytes were homogenized in 100 ml tau lysis buffer (100 mM Tris, vitro with a Ki Å 2.1 mM and does not inhibit several other pH 6.5, 0.5 mM MgCl2, 1 mM EDTA, 1 M NaCl, 2 mM DTT, 50 protein kinases (Klein and Melton, 1996) . Another laboramM NaF, 0.1 mM NaVO4) and centrifuged at 20,000g for 5 min at tory has recently confirmed that lithium inhibits GSK-3b 4ЊC. Supernatants were adjusted to 11 sample buffer, electrophowith a Ki Å 1-2 mM (Stambolic et al., 1996) . resed on 7.5% SDS -PAGE, and analyzed by Western blot using
In this paper, we demonstrate that lithium inhibits GSKprimary antibodies that recognize specific phosphorylated epitopes 3b activity in vivo and mimics the biochemical effect of wnt on tau (PHF-1) or all forms of tau [T14/T46 (Kosik et al., 1988) ].
signaling by leading to stabilization of b-catenin protein in b-Catenin stabilization in oocytes. b-Catenin protein (7 ng per oocyte) or RNA (5 ng/oocyte) was injected into oocytes which were Xenopus oocytes and embryos. Using a novel assay in oothen incubated at 18ЊC with or without 20 mM LiCl for the times cytes, we find that GSK-3b from widely diverse species indicated in Fig. 3 (protein injections) or overnight (RNA injec-(whose development is sensitive to lithium) is equally intions). Oocytes were then lysed (10 oocytes per 100 ml) in oocyte hibited by lithium. We also provide evidence that suggests lysis buffer [20 mM Tris -Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA, that c-jun, which has been shown previously to be inhibited 1 mM PMSF, leupeptin (10 mg/ml), aprotinin (10 mg/ml)] and centriby GSK-3, may be activated in vivo by lithium treatment. LiCl. A second group of embryos was injected with an SV40-luciferase reporter (also 100 pg) and incubated with or without 20 mM LiCl. At stage 12 [when endogenous c-jun is first expressed (Dong et al., 1996) ], 10 embryos were harvested for luciferase assays using the Promega luciferase assay system (Promega) according to the manufacturer's protocol and light output was measured with a scintillation counter.
RESULTS

GSK-3b Activity in Xenopus Oocytes
To study GSK-3b activity within the cellular milieu, we have developed an assay system using GSK-3b expression in Xenopus oocytes. Tau protein, a microtubule-associated protein expressed in mammalian brain, was chosen as a substrate for GSK-3b. Tau is the principal component of the paired helical filaments and neurofibrillary tangles found in GSK-3b (PHF-1) (Lovestone et al., 1994; Otvos et al., 1994) .
injected with tau protein and samples were harvested at 5 min, 30
Thus, tau offers the advantages that it is not normally exmin, 1.5 hr, 3 hr, and 6 hr for Western blot analysis with PHF-1 pressed in oocytes and phosphorylation of specific sites can antibody. In control oocytes (0GSK-3b RNA) (lanes 1-5) tau is be readily followed by Western blotting.
not phosphorylated at Ser-396 or 404 during the 6-hr incubation.
We first determined that tau phosphorylation occurs However, in oocytes injected with GSK-3b RNA (lanes 6-10) PHF1 within a reasonable time frame in vitro and in Xenopus staining can be identified at 5 min and increases in intensity over time. Equal loading of tau protein is shown in lower panels with oocytes expressing GSK-3b. Tau phosphorylation by an antibody that recognizes all forms of tau protein.
has been demonstrated by several labs, but in many studies, analyses required GSK-3b and tau to be coincubated for 30 min to 24 hr (Hanger et al., 1992; Mulot et al., 1994) and coexpression studies in cell lines involved even longer time periods. We have found that GSKmRNA encoding Xenopus GSK-3b (Pierce and Kimelman, 1995) . After 16 hr, tau protein was injected and oocytes 3b will phosphorylate tau within 5 min, both in vitro and in vivo. As shown in Fig. 1 , in vitro phosphorylation of tau were then harvested at multiple time points for analysis by immunoblotting. As shown in Fig. 1B , tau is rapidly (within is evident by incorporation of 32 P within 5 min and this is reflected by the appearance of immunoreactivity to the 5 min) phosphorylated at serines 396 and 404, as determined by immunoreactivity with the PHF-1 antibody, and this PHF-1 antibody, a monoclonal antibody that specifically recognizes tau protein when phosphorylated at serines 396 phosphorylation persists for up to 6 hr. The level of tau protein did not change significantly over this time period, and 404 (Otvos et al., 1994) .
To measure GSK-3 activity within oocytes, bacterially although there was a decrease in electrophoretic mobility in parallel with the increased phosphorylation of tau, as expressed tau protein (Goedert and Jakes, 1990) was injected into stage 6 Xenopus oocytes, which were then incubated determined by immunoblotting with antibodies indifferent to phosphorylation state (Fig. 1B , T14/T46). Thus, the activfor 5 min to 6 hr, lysed, and subjected to immunoblotting with PHF-1 antibody or with antibodies that recognize both ity of expressed GSK-3b can be readily measured in the oocyte without interference from the high-background phosphorylated and unphosphorylated tau. No signal was seen when using the PHF-1 antibody (Fig. 1B) , suggesting phosphorylation by other protein kinases seen in mammalian cell lines (Sperber et al., 1995) . Western blotting the that serines 396 and 404 are not highly phosphorylated under these conditions and consistent with a relatively low same extracts with an anti-GSK-3 antibody showed that GSK-3 was present at equal levels throughout the assay level of endogenous GSK-3 activity. After prolonged incubation, some lower electrophoretic mobility forms of tau were in oocytes injected with RNA but was not detectable in uninjected oocytes (data not shown). detected (Fig. 1B, T14 /46) which may reflect phosphorylation by other protein kinases present in the oocyte.
To test whether lithium inhibits Xenopus GSK-3b in vivo, we applied this oocyte assay system in the presence GSK-3b was then expressed in oocytes by injection of of lithium chloride. Thus, oocytes were injected with GSK3b mRNA as described above, incubated for 16 hr, and then transferred to either control medium or medium containing 20 mM LiCl. Tau protein was injected, oocytes were incubated for 2 hr, and then oocytes were harvested for Western blot analysis as above. As shown in Fig. 2A , PHF-1 immunoreactivity is seen only in oocytes expressing GSK-3b (compare lanes 2 and 3). In the presence of LiCl, the GSK-3b activity is markedly inhibited (lane 4), while the level of GSK-3b protein is not reduced by lithium treatment (Fig.  2B) . The extracellular concentration of LiCl was varied from 0 to 50 mM and GSK-3b activity was measured, as shown in Fig. 2C ; clear inhibition was observed at 5 to 10 mM LiCl and PHF-1 immunoreactivity was nearly undetectable at 20 to 50 mM. It should be noted that, after a 4-hr incubation of embryos in LiCl, the intracellular Li / concentration does not exceed 5% of the extracellular concentration (Breckenridge et al., 1987) . We expect that the intracellular concentrations of LiCl in our experiments are also considerably lower than the extracellular concentration.
Therefore, lithium inhibits Xenopus GSK-3b in vivo, providing a highly plausible explanation for the dorsalizing effect of lithium on amphibian development. Lithium treatment also phenocopies the gskA mutation (loss of GSK-3) in D. discoideum, leading to a failure to produce spores and an expansion of basal stalk cells. To test whether GSK3b from this primitive eukaryote is directly inhibited by lithium, we subcloned GSKA into a Xenopus expression vector and expressed the protein in oocytes. As shown in Fig. 2A , Dictyostelium GSK-3b phosphorylates tau protein (lane 5) as well as GSK-3b from Xenopus (lane 3) and this activity is also inhibited by lithium (lane 6).
Activation of the wnt Signaling Pathway in Xenopus by Lithium
Genetic epistasis experiments in Drosophila have sug-
FIG. 2. In vivo inhibition of GSK-3b by lithium. (A) Xenopus
gested that zeste-white-3/shaggy, the Drosophila homolog oocytes expressing GSK-3b were transferred to OR2/ containing of GSK-3b, is inhibited by wingless signaling, and this has 0 mM LiCl (lanes 3 and 5) or 20 mM LiCl (lanes 4 and 6) and were been confirmed biochemically (Cook et al., 1996) . One con- Moon, 1996). b-Catenin is essential for dorsal axis formaLanes 1, 3, and 4, injection of Xenopus GSK-3b RNA; lanes 5 and tion in Xenopus embryos (Heasman et al., 1994) and also 6, injection of Dictyostelium GSK-3b RNA. (B) Selected samples appears to be stabilized by inhibition of XGSK-3b activity from (A) were analyzed by Western blot using an anti-GSK-3 antibody, which recognizes Xenopus but not Dictyostelium GSK-3b. (Yost et al., 1996) . Thus, activation of the wnt signaling embryos, we assayed b-catenin stabilization, as described by others for Drosophila (van Leeuwen et al., 1994) and Xenopus (Yost et al., 1996) . RNA encoding b-catenin was injected into oocytes with or without coexpression of DNstabilization of b-catenin in embryos (Yost et al., 1996) . DN-GSK-3 also leads to accumulation of b-catenin in oo-GSK-3, a dominant negative form of GSK-3b. DN-GSK-3 has previously been shown to mimic the wnt pathway in cytes (Fig. 3A, lane 3) . Wild-type GSK-3 had no apparent effect on b-catenin accumulation in oocytes (Fig. 3A , lane Xenopus embryos and has recently been shown to lead to LiCl in the buffer. At various times after injection and transfer to LiCl, oocytes were homogenized and processed for Western blot using anti-b-catenin antibody (also a generous gift of Ursula Gluck and Barry Gumbiner). The level of injected b-catenin protein falls in untreated oocytes with an approximate half-life of 1 hr and is almost undetectable by 4 to 6 hr (Fig. 3B, lanes 40 and 60) , while in the presence of lithium, the injected protein persists at considerably higher levels up to 6 hr after injection (Fig. 3B, lanes 4/ and 6/) . This stabilization of b-catenin protein by lithium continues for at least 18 hr after injection (data not shown). Endogenous b-catenin is present at much lower levels in oocytes and is not readily detected under the conditions shown in Figs. 3A and 3B (see Fig. 3B, lane 1) . The recombinant bcatenin contains several copies of the myc epitope at the carboxy terminus causing the protein to migrate more slowly in polyacrylamide gels than endogenous b-catenin. Thus, the injected protein can be readily distinguished from endogenous protein, ruling out the possibility that the protein levels seen in the presence of LiCl represent increased protein synthesis.
Lithium also causes stabilization of b-catenin protein in embryos, as shown in Fig. 3C . b-Catenin protein was injected into the marginal zone of late two-cell embryos. At the four-cell stage, embryos were treated with 0.3 M LiCl regulation by the wnt pathway (Fagatto and Gumbiner, 1994; Yost et al., 1996; Schneider et al., 1996) .
Activation of AP-1 by Lithium
4), consistent with previous observations in embryos and suggesting that GSK-3 is not limiting in this pathway (Yost
The formal possibility remains that lithium leads to bcatenin accumulation through a mechanism that is indeet al., 1996) .
These data indicate that GSK-3 activity is present endogependent of GSK-3 inhibition. We therefore employed an alternative assay of endogenous GSK-3 activity in embryos. nously in oocytes and can be monitored by following bcatenin turnover. To address whether lithium inhibits en-
The transcription factor c-jun has been shown by others to be a substrate for GSK-3, both in vitro and in cell lines dogenous GSK-3, oocytes injected with b-catenin mRNA were cultured in medium containing 20 mM LiCl. As shown overexpressing GSK-3 and c-jun. GSK-3 phosphorylates cjun at Thr-239, Ser-243, and Ser-249 near the DNA binding in Fig. 3A (lane 2) , lithium leads to accumulation of bcatenin to an extent comparable to that of DN-GSK-3, sugdomain, inhibiting DNA binding and thus inhibiting c-jun activity (Boyle et al., 1991; Plyte et al., 1992) . We reasoned gesting that lithium alone can activate the wnt signaling pathway through inhibition of endogenous GSK-3. To demthat if lithium inhibits GSK-3 in embryos, it should lead to an activation of endogenous c-jun. Embryos were injected onstrate that this effect is mediated through stabilization of b-catenin protein rather than increased protein synthesis, at the one-cell stage with a reporter construct containing the collagenase promoter, which includes an AP-1 site, uppurified, recombinant b-catenin protein (gift of Ursula Gluck and Barry Gumbiner) was injected into stage 6 oostream of the luciferase coding region (gift of Nancy Colburn; see Angel and Karin, 1991) . Control embryos were cytes, which were then cultured with or without 20 mM injected with a similar plasmid containing an SV40 prowould block dorsal axis formation induced by DN-GSK-3, as DN-GSK-3 is not expected to act through depletion of moter in place of the collagenase promoter. Embryos were then cultured in LiCl at the concentrations indicated in Fig. myo-inositol. mRNA encoding DN-GSK-3 was injected into a ventral-vegetal cell of 16-cell embryos with or without 4 and harvested at stage 12, when endogenous c-jun activity becomes detectable according to previously published data myo-inositol present. Embryos were then scored at later stages for second axis formation. As shown in Table 1 and (Dong et al., 1996) . Luciferase activity was determined in embryo lysates. In untreated embryos, there is a low level Fig. 5 , coinjection of myo-inositol clearly reduced the frequency and the extent of second axis induction by DNof luciferase activity (Fig. 4) , but in the presence of LiCl this activity is increased more than 20-fold, consistent with GSK-3. The most striking effect is on the anterior extent of the ectopic axes that do form after coinjection of myo-inosilithium inhibition of GSK-3, thus preventing c-jun inhibition by GSK-3. A corresponding increase in AP-1 complex tol and DN-GSK-3. Even in those cases where anterior structures such as cement gland are present (as indicated formation is also seen (by gel retardation assay) in response to lithium treatment (data not shown). In control embryos, in Table 1 ), they are markedly reduced in size compared to those found with injection of DN-GSK-3 alone (not shown). the SV40 promoter-luciferase reporter yields a high level of luciferase expression that is not affected by lithium treatMyo-inositol did not inhibit the synthesis of DN-GSK-3 protein (data not shown) and also had no discernible effect ment (Fig. 4B) . The SV40 reporter is detectable much earlier than the collagenase reporter, beginning at the midblastula on formation of the primary dorsal axis when injected into transition rather than stage 11 to 12, and luciferase activity reaches a level an order of magnitude higher than that from the collagenase promoter in sibling embryos. The values shown in Fig. 4B are thus normalized to maximum activity from the respective promoters.
Complete second axis
Total second axis DN-GSK-3 / DN-GSK-3 / DN-GSK-3 myo-inositol DN-GSK-3 myo-inositol Control tol depletion hypothesis. However, myo-inositol could block dorsal axis induction by lithium through a more indi-* DN-GSK-3 / H2O is significantly different from DN-GSK-3 / rect mechanism that is independent of IMPase inhibition.
Myo-inositol Blocks Ectopic Axis Induced by DN-GSK-3
myo-inositol in both formation of complete second axis and total second axis with a P õ 0.05, by Waller-Duncan statistical analysis.
To examine this possibility, we asked whether myo-inositol
Copyright ᭧ 1997 by Academic Press. All rights of reproduction in any form reserved. Table 1. dorsal blastomeres (data not shown; also reported prestabilization in Drosophila and Xenopus (Peifer et al., 1994; Yost et al., 1996; van Leeuwen et al., 1994; reviewed in viously: Busa and Gimlich, 1989) . Miller and Moon, 1996) . Genetic epistasis experiments in Drosophila have shown that GSK-3b (zeste-white-3/shaggy) antagonizes this pathway and dominant negative forms of DISCUSSION GSK-3 mimic activation of the pathway in Xenopus (Dominguez et al., 1995; He et al., 1995;  Pierce and Kimelman, The remarkable parallels between activation of GSK-3 1995) . In addition, recent biochemical analysis has sugregulated pathways and the effects of lithium on diverse gested that wnt signaling inhibits GSK-3 enzymatic activity pathways have suggested a novel mechanism for lithium (Cook et al., 1996) . We show here that lithium, like domiaction, as proposed previously (Klein and Melton, 1996) . nant negative GSK-3, activates the wnt pathway by antagoThus, GSK-3 inhibits the wnt signaling pathway, glycogen nizing GSK-3 function, as assessed by stabilization of bsynthesis, and, in Dictyostelium, stalk cell specification, catenin in oocytes and embryos. Stabilization of b-catenin and in each case lithium treatment stimulates these pathis seen for injected protein, but changes in endogenous levways, consistent with direct inhibition of GSK-3 by lithium. els are not detectable in our assays, presumably because The data presented here demonstrate in vivo inhibition of the majority of the endogenous protein is sequestered in GSK-3 by lithium and consequent downstream activation complexes with cadherin and not accessible to regulation of the wnt signaling pathway in Xenopus laevis oocytes by the wnt pathway (Fagatto and Gumbiner, 1994; Yost et and embryos. Similar conclusions were reached in recently al., 1996; Schneider et al., 1996) . We have also found that published work using PC12 and S2 tissue culture cells LiCl treatment of Drosophila S2 cells leads to accumulation (Stambolic et al., 1996) . Both vertebrate (Xenopus as well of armadillo protein (C. M. Hedgepeth and P. S. Klein, unas mammalian) and invertebrate (Dictyostelium and Dropublished data; see also Stambolic et al., 1996) . sophila) forms of GSK-3b are inhibited by lithium, showing Activation of the wnt pathway by lithium explains an that the sensitivity of GSK-3 to lithium is conserved across intriguing parallel between ectopic wnt expression and a broad phylogenetic spectrum. These data support the hylithium treatment in Xenopus embryos: It has been obpothesis that inhibition of GSK-3 is a general mechanism served previously that expression of Xwnt-8 prior to the for lithium action in these settings and are consistent with midblastula transition (MBT) results in dorsalization, as our previous findings that purified GSK-3 is inhibited by discussed above, while expression of Xwnt-8 after MBT lithium in vitro (Klein and Melton, 1996) . results in truncations of dorsal -anterior structures (ChrisActivation of the wnt signaling pathway results in accumulation of b-catenin or armadillo protein due to protein tian et al. , 1991, 1993) . Remarkably, the responses to lith-ium are very similar: exposure to lithium prior to MBT weeks to manifest a clinical response. It has been suggested that this delay reflects changes in gene expression rather dorsalizes and exposure after MBT leads to similar dorsalanterior truncations (Cooke and Smith, 1988;  Yamaguchi than an immediate effect on signal transduction mechanisms (Manji et al., 1995) . Thus, lithium's ability to stimuand Shinagawa, 1989) .
Our assays show that b-catenin protein is being rapidly late AP-1 regulated transcription, as well as the nuclear localization of b-catenin, suggests two mechanisms to conturned over in oocytes (as previously shown in embryos). Since this turnover can be inhibited by DN-GSK-3b (as well vert short-term responses to lithium into long-term changes in gene expression. as by lithium), endogenous GSK-3 must be present and active in the oocyte, although at a level below the sensitivity The inositol depletion hypothesis has been a compelling and widely accepted explanation for the developmental efof the tau phosphorylation assay or of antibody detection. It remains to be seen whether oocyte GSK-3 activity and bfects of lithium. However, while lithium does inhibit IMPase in vivo (Maslanski et al., 1992 ; Klein and Melton, catenin turnover represent a constitutive process or serve an unknown function in the oocyte. At present, the ability 1996), a far more potent inhibitor of IMPase, L-690, 330, does not dorsalize embryos, strongly suggesting that inhibito recapitulate part of the wnt signaling pathway in oocytes will provide a valuable tool for studying the biochemistry tion of IMPase is not sufficient for the developmental effects of lithium. Why then does coinjection of myo-inositol reof wnt signaling in an in vivo setting.
As an alternative assay of GSK-3b in embryos, we examverse the effect of lithium (Busa and Gimlich, 1989) ? One explanation could be that depletion of inositol is necessary, ined the activity of the transcription factor c-jun, which binds DNA as part of the AP-1 complex (Angel and Karin, but not sufficient, for the teratogenic effect of lithium. Alternatively, injection of 0.3 M inositol could have a more 1991). DNA binding and transcriptional activation by c-jun have been shown by others to be inhibited by GSK-3 (Boyle indirect effect on ectopic axis formation that is unrelated to partially depleted inositol pools. To distinguish between et al., de Groot et al., 1992; Nikolakaki et al., 1993) . Thus, our prediction was that lithium should activate c-jun
these two possibilities, we tested whether inositol would block dorsalization by factors not expected to deplete inosiby inhibiting GSK-3. In untreated embryos, we observed a low level of activity through an AP-1-dependent promoter tol. Thus, we have shown that injection of myo-inositol can block dorsalization by DN-GSK-3. While the mechanism of when compared to other promoters (e.g., SV40 -luciferase), but also observed a marked increase in the presence of lithmyo-inositol rescue is uncertain, it seems unlikely that DN-GSK-3 is also acting through depletion of inositol. ium chloride, without any effect on the control promoter. This observation is consistent with constitutive inhibition Rather, the data suggest that injected inositol or a metabolite acts through some pathway independent of IMPase to of endogenous jun by GSK-3 which is then reversed by lithium. However, it has not been technically possible to map reverse the consequences of inhibition of GSK-3, whether that inhibition is mediated by lithium or through DN-GSKthe phosphorylation sites in c-jun after lithium treatment, as the endogenous protein levels are very low in stage 12 3. It should be pointed out, however, that our data do not rule out a role for IP 3 signaling in axis determination in embryos (data not shown). Thus, it remains possible that lithium activates AP-1-dependent transcription through alXenopus, independent of the effects of lithium. Indeed, artificial activation of phospholipase C in dorsal blastomeres ternative mechanisms, including activation of jun N-terminal kinases or activation of the fos protein, which can also causes ventralization of Xenopus embryos, raising the possibility that IP 3 and/or diacylglycerol are involved in ventral participate in AP-1 complex formation. Others have reported that stimulation of AP-1 activity by NGF or pilocaraxis determination normally (Ault et al., 1996) . A number of other hypotheses have been advanced to pine is enhanced by cotreatment with lithium, as determined by gel retardation assays (Bullock et al., 1994; Wil- explain the mechanism of lithium action, including but not limited to inhibition of trimeric G-protein function and perliams and Jope, 1995) . We have also observed increased AP-1 complex formation after lithium treatment, as measured turbation of ion flux across membranes (reviewed in Gilman et al., 1990; Jope and Williams, 1994) . These hypotheses by gel retardation assays, consistent with inhibition of GSK-3 by lithium (data not shown). However, these data do not have not been addressed directly in this work. In addition, a family of structurally related enzymes, including fructose distinguish whether the increase in AP-1 binding is due to direct stimulation of c-jun or removal of an inhibitor of jun 1,6-bisphosphatase and inositol polyphosphate 1-phosphatase, has been identified and shown to be inhibited by lithactivity.
Thus, three lines of evidence argue that lithium inhibits ium (York et al., 1995) . The possibility that these enzymes play a role in signal transduction and the pharmacology of GSK-3 activity in embryos: (1) Lithium leads to stabilization of b-catenin protein in Xenopus embryos, as well as oocytes; lithium action is currently under study (J. York, personal communication). (2) lithium stimulates nuclear translocation of b-catenin in Xenopus embryos (Schneider et al., 1996) as well as sea Inhibition of GSK-3b by lithium offers a highly plausible molecular mechanism for the effects of lithium on developurchin embryos (J. R. Miller and D. R. McClay, personal communication) ; and (3) lithium appears to activate AP-1 ment in diverse organisms from Dictyostelium to vertebrate embryos and this hypothesis is strongly supported by activity in Xenopus embryos as well as mammalian cells. In the treatment of manic-depressive disorder, lithium does genetic as well as biochemical data. The intriguing possibilities that GSK-3b is the target of lithium in the treatment not have an immediate effect, but rather requires several
